Date: January 23, 2024
Time: 12:00 PM—1:00 PM EST

This presentation is intended to provide information for public health and prevention professionals about xylazine, a new compound that is in the white powder (opioids and stimulants) drug supply, and its effects. This presentation will discuss what xylazine is, current data on it’s prevalence in the New England region, and effects of xylazine. It will also discuss a harm reduction approach in the setting of patients with substance use disorder, stressing that one can help someone who may not be ready for complete abstinence from harmful drug use.